Close Menu

NEW YORK ─ Streck said on Friday that the US Food and Drug Administration has granted de novo clearance for use of its Cell-Free DNA BCT blood collection tube with the Guardant Health Guardant360 CDx liquid-biopsy companion-diagnostic assay.

Cell-Free DNA BCT is the first circulating nucleic acid blood collection tube to be cleared for use with liquid biopsy, Streck said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.